Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.

Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.

Item

http://www.wikidata.org/entity/Q34982646

Q34982646

about

Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates HIV vaccine trial exploits a dual and central role for innate immunity.Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection.A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys New paradigms for HIV/AIDS vaccine development.Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model.The role of Fc receptors in HIV prevention and therapy.Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV.A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001 Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses.Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.Role of Fc-mediated antibody function in protective immunity against HIV-1.Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.Use of broadly neutralizing antibodies for HIV-1 prevention.Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.In vitro inhibition of HIV-1 replication in autologous CD4(+) T cells indicates viral containment by multifactorial mechanisms.Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors.Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region.Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak.

P2860

Q31138949-4ECCDA4F-551B-4FFA-A683-64A6AE693CBB Q33355730-501782C7-C01E-4EF8-8C84-C181DB200465 Q34261579-CCA3E1DE-8083-4740-BE35-AEC0403FC67C Q34592776-F90490F7-9344-4E71-AA5B-299A585755AB Q34637668-149D5B82-5BE0-4DF0-AB0E-60FD6713A992 Q35077793-DE0775E7-E50F-4E2E-8147-458C2F7B21E9 Q36011269-6DADEA6E-12B6-4BE2-A101-016949753120 Q36013396-34110E46-97A0-471C-A133-204A5A12D8EC Q36249933-D37E805B-8522-4C67-A6D3-F6795E3BCDE7 Q36252656-E3B38684-0B08-4F26-B03C-3AD0DEBBADED Q36754331-80022E31-0FC8-4B7E-A84C-D8826FC660A1 Q36797342-A1B805E0-9D9C-4930-9A59-F15A8B0DBE46 Q36939751-3CAE5F3B-3C49-432C-B57D-18C978EDF317 Q37113972-0AAA969B-EB34-402D-8848-A18658ABFBB9 Q37305694-9A5BBB04-07F8-44D2-8668-38DA9323D4F0 Q37319976-0419212F-E156-4353-A0AF-35409C9B8DD2 Q37409262-0A3DE413-9A4F-4875-BBA1-13C04EE01A26 Q37497214-F255ADF3-8E8B-4076-A39F-005AC269A68F Q37643973-98485A50-7AC5-4A8B-B179-0D7FD7E16D21 Q37646897-260914BD-6EEF-4E7F-B36E-1109DBD5FF51 Q38213061-3ADE03A9-C347-463C-93FE-17A38055C522 Q38688524-6490EE27-CCFF-49B0-AE71-4F11B4EB8F36 Q38764543-59B74E63-E3DA-4C99-A80D-403FD7BDBEAA Q41119832-C371AD81-F04D-416B-B36A-5B0E2D4F8DEB Q41885613-13811900-4AE3-40D1-8858-46AE61B9AB4D Q41936036-0A2918E6-36CD-404D-A36E-09E27D969CEE Q46296261-1A3398B3-4FA8-4343-A57F-9DE8AD7A56B4 Q46632788-A8FDA4C2-D772-4E23-A5EC-F78A199262D2 Q47604797-1AE7A3AE-EF23-44C6-8F50-6862331160EE Q52595348-768CBFFB-6A49-4DFE-8B53-0542FC563D09

P2860

Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.

Item

http://www.wikidata.org/entity/Q34982646

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu